These changes, highlighted by the upregulation of KIF1B, VEGFC, BTG2, DOCK4, SHCBP1L, ATF3, and SPRR2E, underscore the tumor’s capacity for invasion, metastasis, and adaptation within a dynamic TME62–69. The gene discussed is BTG2; the disease is neoplasm.